Business targets

Aiforia does not publish short-term outlooks or financial targets. However, the company has set short- and medium-term business targets at the time of the IPO.

Aiforia’s short-term business targets 2021–2023:

• Obtain a CE-IVD marking for six AI models intended for clinical diagnostics
• Acquire five customers in clinical diagnostics
• Acquire ten large customers in the pharmaceutical industry
• Reach more than 5,000 users

Aiforia’s mid-term business targets by the end of 2030:

• Create a product offering that covers 80% of the pathologist’s diagnostic workflow
• Achieve a positive cash flow from operating activities by the end of 2025
• Achieve revenue of more than EUR 100 million
• Reach 20,000 users
• Achieve 50 key customer relationships that would generate an annual recurring revenue of at least EUR 250,000 per customer.